Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360) | Synapse
November 16, 2022Current Oncology59 citationsOpen Access
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)